Literature DB >> 16143329

CNTF induces dose-dependent alterations in retinal morphology in normal and rcd-1 canine retina.

Caroline J Zeiss1, Heather G Allore, Virginia Towle, Weng Tao.   

Abstract

Ciliary neurotrophic factor (CNTF) provides morphologic preservation of rods in several animal models of retinitis pigmentosa (RP). However, CNTF may alter photoreceptor morphology and rod photoreceptor differentiation in vitro, as well as affecting normal retinal electrophysiology. In addition, the capacity of CNTF to support other cell types affected secondarily in RP (cones and ganglion cells) is unclear. The purposes of this study were to examine the effects of CNTF upon a canine model of RP, the rod-cone degeneration (rcd-1) dog. Archival tissue from a previous study assessing the capacity of CNTF to rescue photoreceptors in rcd-1 dogs was used. One eye was treated for 7 weeks before being explanted. The contralateral eye was untreated. A total of 23 rcd-1 dogs and seven control dogs (four untreated and three CNTF-treated) were used. Morphometric data describing outer and inner nuclear layer thickness, inner retinal thickness, cones and ganglion cells were collected at nine evenly spaced points along each retina and analysed using a mixed effects model. Immunohistochemistry was performed on a subset of 11 dogs for expression of rhodopsin, human cone arrestin (hCAR) and recoverin. CNTF protected the outer nuclear layer and increased inner retinal thickness in a dose-dependent manner (both were maximal at CNTF doses of 1-6 ng day-1). Significant cone loss or reduction of inner nuclear layer width in rcd-1 did not occur in this model, therefore we were unable to assess the protective effect of CNTF upon these parameters. CNTF did not afford significant ganglion cell protection. CNTF induced morphologic changes in rods and ganglion cells, as well as reducing expression of hCAR and rhodopsin, but not recoverin. The dose of CNTF which provided optimal outer nuclear layer protection also resulted in several other effects, including altered ganglion cell morphology, increased thickness of the entire retina, and reduced expression of some phototransduction proteins. These changes were more marked in rcd-1 retinas than in wild-type retinas. This implies that the consequences of CNTF treatment may be substantially influenced by the cellular context into which it is introduced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143329     DOI: 10.1016/j.exer.2005.07.014

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  16 in total

Review 1.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

2.  Evidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutation.

Authors:  Samuel G Jacobson; Alexander Sumaroka; Tomas S Aleman; Artur V Cideciyan; Michael Danciger; Debora B Farber
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

3.  Chronic intravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat.

Authors:  Tiffany L Kent; Inna V Glybina; Gary W Abrams; Raymond Iezzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

4.  Retinal remodeling in the Tg P347L rabbit, a large-eye model of retinal degeneration.

Authors:  B W Jones; M Kondo; H Terasaki; C B Watt; K Rapp; J Anderson; Y Lin; M V Shaw; J-H Yang; R E Marc
Journal:  J Comp Neurol       Date:  2011-10-01       Impact factor: 3.215

Review 5.  CNTF and retina.

Authors:  Rong Wen; Weng Tao; Yiwen Li; Paul A Sieving
Journal:  Prog Retin Eye Res       Date:  2011-12-10       Impact factor: 21.198

6.  Exogenous modulation of intrinsic optic nerve neuroprotective activity.

Authors:  Sinisa D Grozdanic; Tatjana Lazic; Markus H Kuehn; Matthew M Harper; Randy H Kardon; Young H Kwon; Erin B Lavik; Donald S Sakaguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-13       Impact factor: 3.117

Review 7.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

8.  CREB1/ATF1 activation in photoreceptor degeneration and protection.

Authors:  William A Beltran; Heather G Allore; Elizabeth Johnson; Virginia Towle; Weng Tao; Gregory M Acland; Gustavo D Aguirre; Caroline J Zeiss
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

9.  Drusen and photoreceptor abnormalities in African-Americans with intermediate non-neovascular age-related macular degeneration.

Authors:  Sam Sadigh; Xunda Luo; Artur V Cideciyan; Alexander Sumaroka; Stacy L Boxley; Laura M Hall; Rebecca Sheplock; William J Feuer; Dwight S Stambolian; Samuel G Jacobson
Journal:  Curr Eye Res       Date:  2014-06-09       Impact factor: 2.424

10.  Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa.

Authors:  David G Birch; Richard G Weleber; Jacque L Duncan; Glenn J Jaffe; Weng Tao
Journal:  Am J Ophthalmol       Date:  2013-05-10       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.